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ETIOLOGY OF SCARLET FEVER*
DR. A. R. DOCHEZ

Professor of Medicine, College of Physicians and Surgeons, Columbia
University, New York

S

CARLET FEVER is in all probability a very old disease.
The regions in which the malady originally arose are a mat
ter of uncertainty. There are some who believe that the Plague
at Athens was a malignant form of scarlet fever, an interesting
assumption in view of the present relatively low case fatality and
the ominous variability in severity of outbreaks in the past.
Fairly accurate descriptive records of scarlet fever appear in the
literature as early as the middle of the sixteenth century and
recur with increasing frequency and definiteness up to the time
of Sydenham. For many years the disease was confused with
measles, erysipelas, diphtheria and certain septic processes.
Sydenham, who first employed the name scarlet fever, clearly
differentiated it from measles by his careful description of the
disease as it appeared in London from 1661 to 1675, and laid
the foundation of an accurate knowledge of its special characters.
In spite of this valuable contribution, the existing confusion did
not disappear, and many physicians still confounded it with
diphtheria and certain septic anginas. With the increasing
volume of medicar literature and better facilities for the com
munication of ideas, scarlet fever became mol'e and more clearly
defined as a clinical entity. Confusion, however, with diphtheria
frequently occurred, even down to the times of accurate diag
nosis by means of bacteriological methods. In fact, even today
the inability to differentiate scarlet fever from certain septic
conditions of the throat, associated with erythematous rashes,
continue� to plague the mind of the diagnostician. In spite of
these diagnostic difficulties clinical differentiation of scarlet fever
from other e:x:anthemata has been possible for a long �ough
* Lecture delivered January 17, 1925.
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period of time to determine clearly its contagious nature and to
permit illuminating epidemiological and clinical studies.
The contagious element in scarlet fever is probably always
derived from a previous case. In most instances it is taken
directly into the mouth or nasopharynx by the inhalation of air
charged with minute droplets of saliva or mucous projected from
the mouth or nose of the infected individual. Other important
sources of contagion are the purulent discharges from infected
paranasal sinuses, from suppurative inflammation of the middle
ear and lymph glands, secondary conditions that constitute the
most frequent and distressing complications of the disease.
There is much evidence to support the view that the causative
organism survives in the dry state in a virulent form for long
periods of time. Contamination, therefore, of clothing or per
sonal articles of any kind with infective matter may serve as a
means of conveying scarlet fever. Formerly the belief was
quite prevalent that flakes of skin given off during the period
of desquamation were ·the most important vehicle of the con
tagion, and quarantine regulations were roughly founded on
time periods corresponding with the duration of the desquama
tive stage. Current opinion .holds that the contagious element is
not present in the skin in the late stages of scarlet fever, a some
what curious fact, inasmuch as the rash is the most distinctive
clinical manifestation of the disease. The role of the healthy
carrier in spreading scarlatina is undoubtedly ·of great impor
tance but determined accurately as yet in only a very few
instances because of the uncertainty concerning the etiological
agent.- That such types of carriers do exist there can be no
doubt, and Bliss 1 has been able . to. trace a small epidemic of
scarlet fever to such a source. Another interesting means of the
wide dissemination of scarlet fever is an infected milk supply
and numerous undoubted outbreaks have arisen from the con
sumption of contaminated milk. The clinical and epidemiologi
cal evidence, therefore, that has been collected indicates that the
causative agent of s_carlet fever is present in the throat secretions
and the discharges from suppurative foci in patients throughout
the illness, and for a considerable period of time during con-
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valescence. It resists -exposure to light, and in the dry state may
retain its infectivity for many months. Healthy carriers and
atypical attacks of the disease are not an infrequent occurrence.
In all probability the udder of the cow may become infected with
the specific virus, and the milk obtained from this animal may
serve as a vehicle of infection.
Notwithstanding these excellent clinical and epidemiological
studies which have ensured the easy recognition of typical
attacks of the disease, and which have furnished the essential
data for useful quarantine regulations, the causative organism
of scarlet fever has remained unknown. Experimental studies
have been published from time to time, suggesting that the infec
tive agent belongs to one or other of the principal groups of
microorganisms, such as the pathogenic bacteria, protozoa, and
the so-called ultra.microscopic viruses. As a bacterial cause,
Streptococcus hremolyticus has aroused much interest and stimu
lated more or less continuous investigation because of its con
stant association both with the uncomplicated and complicated
forms of the disease. Certain observers have discovered inclusion
bodies in leucocytes and in epidermal cells which they have
thought indicative of a protozoan cause for scarlet fever.
Finally, scientific opinion seized upon those mysterious living
bodies commonly designated as filterable viruses as the most
probable cause of the disease. This latter view has become most
widely accepted and is the usual etiology assigned in text books
in spite of the fact that no real evidence has ever been produced
to show that any such microorganism exists either in the
throat secretions, tissues or blood of an individual suffering
from scarlatina.
Both Mallory 2 and Dohi'e 3 have made the suggestion that
scarlet fever may be due to a protozoan infection. In 1904 Mal
lory observed in four cases of scarlet fever certain bodies whose
varying morphology strongly suggested that they might have
been stages in the development cycle of a protozoan. They
occurred in and between the epithelial cells of the epidermis and
free in the superficial lymph vessels and spaces of the. corium.
They formed a series of bodies including definite rosettes, which
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closely resembled those seen in the asexual development of the
malarial parasite. There were also certain coarsely reticulated
forms which he thought might represent stages in sporogony.
Mallory was of the opinion personally that these bodies were
protozoa and bore an etiological relationship to scarlet fever, but
he did not regard their significance as established. Confirmatory
observations were subsequently made by Duval/ Bernhardt G
and v. Prowagek.0 Similar bodies, however, were later found by
Field 7 in other conditions and they finally came to be looked
upon as p.eculiar products of cell degeneration and not as living
.forms with a specific relationship to scarlet fever.
In 1912 Dohle,on examining the blood smearsfrom thirtycases
of scarlet fever, found within the cytoplasm of the neutrophilic
polynuclear leucocytes multiform inclusion bodies. These inclu
sions were present in a large percentage of all leucocytes and by
special methods of staining revealed themselves as intermediate
in intensity between nucleus and cytoplasm. In a later communi
cation certain of these inclusions are designated as '' Spirochrota
scarlatin�,'' and are assigned both diaITTJ.ostic and prognostic
importance. Although numerous observ:ers confirmed Dohle's
observations on the presence of leucocytic inclusion bodies, fur
ther study revealed the fact that they are present in practically
all febrile conditions, in chronic pyogenic infections without
fever, in certain severe injuries, and occasionally in normal
human beings. In all likelihood they result from nuclear degen
eration not infrequently observed in septic states and have no
specific bearing on the etiology of scarlatina. The evidence
offered in favor of the protozoan origin of scarlet fever has never
stood the test of close scrutiny.
The belief that scarlet fever is due to an unknown virus,
probably of filtrable character, is based largely upon the results
of attempts to communicate the disease experimentally to ani
mals. A number of observers have reported scarlatina-like mani
festations in monkeys inoculated with infective material from
active human cases of the disease. Among these observations the
most interesting are those of Leva<liti, Landsteiner and Prasek,8
who, by the inoculation of anthropoid apes, seem to have pro-
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duced what in all likelihood was true scarlatina. Exudate from
the throats of individuals with scarlet fever was rubbed into the
tonsils of apes and defibrinated blood injected subcutaneously,
and in one instance material from a suppurating lymph gland.
The animals, after an incubation period of about three days, are
described as having a typical angina with characteristic exudate,
enlargement of the follicles of the tongue, a generalized exanthem
resembling that of scarlet fever, and in certain instances when
the animals recovered desquamation of the skin. There was also
present the characteristic lymphoid hyperplasia, and the histo
logical lesions in the skin resembled those seen in scarlet fever.
In all the animals presenting such a picture S. hremolyticus was
present, either in the blood or in the local lesions in the
throat. Levaditi, Landsteiner and Prasek, however, did not
think that streptococcus was accountable for the manifestations,
inasmuch as when pure cultures of this organism were obtained
from the infected animals or from human beings and inoculated
into fresh apes, the phenomenon described could not be repro
duced. They do not state that the organism of scarlet fever is a
filtrable virus, but simply say that it is of unknown character
istics. Cantacuzene 9 and. Bernhardt 10 claim to have induced a
similar series of phenomena by the inoculation of monkeys of a
lower order with human material. Levaditi, Landsteiner and
Prasek failed to produc,e in a large series of lower monkeys the
disease syndrome manifested by the apes, nor were subsequent
investigators more successful in confirming the observations of
Cantacuzene and of Bernhardt. From the failure to discover an
organism of known characteristics, rather than from any posi
tive evidence has grown the belief so generally held that the
etiological agent of scarlatina is an ultramicroscopic virus.
During the many years that investigators have searched for
the causative agent of scarlet fever, and with the varying
emphasis attached t o one or another species of parasite from
time to time, the constant relationship to this disease of ·one
organism, S. bremolyticus has become more and more significant.
As early as 1885 Crook 11 reported the presence of streptococcus
in the blood and organs of individuals dying of scarlet fever.
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Loeffler, 12 in addition, found this organism to be present in cer
tain types of necrotic angina associated with scarlet fever and
was furthermore successful in isolating the germ in pure culture.
At this time Klein 13 lilrnwise isolated a streptococcus from the
tissues of patients with scarlatina, which he named Streptococcus
scarlatinre. In 1885 the latter observer, while investigating an
outbreak of fever among certain cows belonging to a farm at
Hendon, England, isolated from ulcerative lesions of the udders
and from certain viscera, a streptococcus which he considered
to be identical with Streptococcus scarlatinre. This observation
was not only of great interest but also of very great importance,
because the milk obtained from the infected cows was shown to
have been consumed by persons who subsequently developed
scarlet fever. 'l'hese early observations of the frequent relation
ship of streptococcus to scarlatina were soon confirmed by many
students of the disease in different parts of the world. In 1900
Baginsky and Sommerfeld 14 reported the constant presence of
streptococcus in the throat during the characteristic angina in
seven hundred cases of scarlet fever. They also found this
organism frequently in the blood, bone marrow and internal
organs of patients dying of this disease. Other observers found
streptococcus in the blood of fatal cases of scarlet fever in as
many as 70 per cent. of the individuals studied. Hektoen,15 fur
thermore, found the organism in the blood in 12 per cent. of
patients during life, and his observations are of especial interest
in that they indicate'that the usual bad prognostic import of this
phenomenon does not necessarily hold for scarlet fever.
In· addition to the presence of streptococcus in the throat and
blood of individuals with scarlet fever, this organism has also
been proven to be the m9st frequent cause of the septic com
plication.'> of the disease. Many times in septic foci streptococcus
has been found in pure culture, and it is an old observation that
convalescent individuals with discharging suppurativ.e lesions
are especially likely to give rise to return cases of scarlet fever,
showing that in such lesions the causative virus persists in an
active form for long periods of time.
S.11-ch wideSP,read and COJ)Stant assoqiation of S.. hremol rticus
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with scarlet fever has led some investigators to propose the view
that streptococcus is the etiological agent of this disease. Certain
observers, on the other hand, oppose this belief and have con
sidered it more likely that streptococcus plays in scarlatina the
role of a secondary invader. The objections of this latter group
to the etiological significance of streptococcus are based upon
certain important considerations. As is well known, strepto
coccus is an organism of very widespread distribution and gives
rise to a variety of pathological lesions, such as abscess forma
tion, cellulitis, septicremia and numerous other conditions. Fre
quently the same individual may have throughout life repeated
streptococcus infections, one attack not seeming to confer immu
nity against subsequent invasion of the tissues by the same
organism. The latter condition of affairs is especially true of
erysipelas, one of the most characteristic of the streptococcus
diseases. On the other hand, scarlet fever, in sharp contrast to
other streptococcus infections, is a fairly definite clinical entity
and one attack appears to give rise to an immunity of life-long
duration. This peculiarity of scarlet fever might have been
explained had it been possible to prove that the streptococcus
associated with scarlet fever differed specifically from the hremo
lytic streptococci causing the various septic processes. However,
early cultural and biochemical studies have failed to demonstrate
any significant differential characteristics by means of which
Streptococcus scarlatinre could be separated biologically from
similar streptococci found in other diseases. When grown in
fluid or in solid media, hremolytic streptococci resemble one
another very closely, whatever be their source. It is true that
certain constant differences can be brought out by means of fer
mentation of various carbohydrates, but such variations as exist
apparently do not bear any specific relationship to a single dis
ease process, and have been of but little aid in determining the
etiological significance of streptococcus in scarlet fever. In
addition to this object.ion, 'Jochmann 10 has emphasized especially
his failure to find streptococcus in either blood or tissue of indi
viduals dying in a few days from malignant forms of the disease.
Since, therefore, types of streptococci indistinguishable from
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those seen in scarlatina are found in a great v,ariety of disease
conditions, and since the quality of the immunity in this disease
differs widely in its duration from that observed in other strepto
coccus infections, and finally because of Jochm.ann 's contention
that streptococcus is not present in certain malignant types of
scarlet fever, the conclusion has been drawn that streptococcus
cannot be the cause of the disease.
An effort to meet these objections has been made by the group
of investigators who believe that streptococcus is the etiological
agent of scarlet fever. The observation by Baginsky and Som
merfeld of the constant presence of S. hremolyticus in the throats
of all cases of scarlatina, an observation later confirmed by others,
has done much to offset the inferences drawn from Jochmann 's
failure to find it in a few instances of fulminant types, especially
since we now know that the organism in the latter cases may have
been localized in some inaccessible area. Attempts were made
in addition to explain the immunity in scarlet fever and to estab
lish the type specificity of the scarlatina! streptoco:ccus. Moser 17
and Moser and Pirquet 18 have claimed that scarlatinal conva
lescent serum agglutinates to a higher titer Streptococcus scarla
time than does control serum from other diseases. Furthern'lore,
they have prepared polyvalent serum from horses, using the
streptococcus of scarlet fever as antigen and have studied the
capacity of such sera to agglutinate specifically various strains
of scarlatinal streptococci. The latter strains were agglutinated
in dilutions of 1: 1000 or over, whereas hremolytic streptococci
from other sources were not specifically agglutinated. As a con
sequence of these observations Moser and Pirquet believed that
the streptococcus of scarlet fever differs specifically from appar
ently similar strains isolated from instances of erysipelas,
phlegmon and puerperal sepsis. Meyer 10 and Rossiwall and
Schick 20 have confirmed the results of Moser and Pirquet. Unfor
tunately, however, certain later studies by Hasenknopf and
Salge,21 Aronson, 22 and Neufeld 23 failed to support the earlier
ones and grave doubt was thrown upon the specificity of Strepto
coccus scarlatinre.
Other interesting facts which indicate the specific relation-
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ship of streptococcus to scarlet fever have come from the studies
of Gabritchewsky 24 on the specific prophylaxis of scarlet fever
by means of a vaccine prepared from S. scarlatinre, anµ of
Moser 25 on the therapeusis of the disease by means of a specific
antistreptococcus serum. Gabritchewsky and his co-workers
immunized a large number of individuals against scarlet fever
with a vaccine prepared from hremolytic streptococci isolated
from scarlatina. During the process of immunization certain phe
nomena occurred which were highly suggestive of the clinical
manifestations of scarlet fever. In the majority of instances an
area of erythema and swelling averaging 15 cm. in diameter
developed at the site of the vaccine injection appearing in from
eight to twenty-four hours and lasting about forty-eight hours.
In general, the erythema was diminished or absent following a
second injection some ten days later. In about 15 per cent. of
the individuals inoculated a general reaction was observed. This
general reaction consisted in fever of 1 ° C. or so, leucocytosis and
an erythematous rash, having the characteristic distribution of
the exanthem in scarlet fever. Some of those inoculated showed
the typical ·angina and strawberry tongue peculiar to the disease
and in a few instances signs of renal irritation were observed.
In general individuals who were recovering from the disease or
who had had it some years before failed to show either a local
or general reaction. Administration of Moser's antiscarlatinal
serum before the inoculation was shown to prevent the develop
ment of both a local and a general reaction. Prophylactic
immunization of this type seemed to diminish the incidence of
scarlet fever among the inoculated. As a result of these observa
tions Gabritchewsky and his assistants were strongly of the opin
ion that streptococcus is the causative agent of scarlet fever.
The therapeutic results obtained by the use of Moser's serum
lent further support to this view. Moser immunized horses to
hremolytic streptococci obtained from the blood of patients suf
fering from scarlatina. The serum thus prepared was used
therapeutically and is said to have had marked beneficial effects
causing a drop in the temperature and pulse, a diminution of the
toxremia, early disappearance of the rash and a marked short-
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ening of the duration of the disease. Escherich, who observed
the work closely, was mnch impressed by the therapeutic value
of the serum and likened its action to that of diphtheria anti
toxin. Later antistreptococcic sera prepared by other investi
gators, however, failed to display the therapeutic efficiency of
l\foser's serum and created doubt in the minds of many concern
ing the usefulness of such sera.
Much other evidence both for and against the etiological rela
tionship of streptococcus to scarlet fever was presented at this
time and as one weighs its importance in retrospect, the positive
seems of more significance than the negative. The outstanding
objection, however, to the acceptance of streptococcus as the cause
of scarlet fever remained the impossibility of differentiating
satisfactorily this organism from hremolytic streptococci asso
ciated with the great variety of septic conditions. As a result,
other etiologic agents were searched for. Moser's serum dropped
into disuse and streptococcus vaccine was no longer used in the
prophylaxis of scarlet fever. Scientific opinion gradually came
to hold that streptococcus bore an important but secondary rela
tionship to scarlet fever, and tha.t the true cause must be sought
among the unknown viruses.
For many years confusion has existed and opinion has varied
concerning the existence of biologically varying types of strepto
coccus. Two diverging points of view developed, one maintain
ing the unity of the species as a type, and the other holding that
it comprised a group of organisms different from one another in
their biological characteristics. Schottmiiller 26 in 1903 made an
important contribution to the discussion in demonstrating
between certain streptococci, differences based on their action
on blood agar plates, one group hremolyzing the red blood
cells and the other either failing to hremolyze or forming methem
oglobin. This significant differentiation resulted in the
establishment of the types now generally recognized as hremo
lytic and nonhremolytic or green pigment producing strains.
Further classification was attempted by numerous investigators
who used as a basis of differentiation certain biochemical reac
tions. Holman 27 in 1916, using carbohydrate fermentation as a
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test, was able to demonstrate the existence of a number of sep
arate fermentation types. Numerous efforts were also made to
establish biological differences, especially among the hremolytic
streptococci, by means of serological reaction methods which
had proven singularly successful when employed for studying
the various types of pneumococcus and meningococcus. As a
result of these studies conflicting beliefs arose, and a definite
opinion could not be giYen as to whether or not separate bio
logical types of S. hremolyticus exist. As late as 1918 Swift and
Kinsella, 28 using the complement :fi.--i::ation reaction as a test, made
a series of observations of twenty-eight strains of hremolytic
streptococcus from various sources. They found that they were
unable to determine significant serological differences between
the strains studied and are of the opinion that a striking homo
geneity exists. Efforts to correlate such different types of hremo
lytic streptococcus as had been determined with specific
pathological lesions were also of indeterminable significance,
varying types being found in association with the same disease.
In 1918 Dochez, Avery, and Lancefield 20 undertook a bio
logical study of a great number of strains of S. hremolyticus,
obtained from a variety of pathological conditions among the
changing population of a large military establishment. The pur
pose of this investigation was to determine if there exist among
the hremolytic streptococci diverse biological types, as is the case
in the instances of pneumococcus and meningococcus. The spe
cific test reactions were those of agglutination and protection.
Spontaneous non-specific flocculation, the most confusing factor
in previous studies of specific agglutination of streptococcus, was
avoided by the employment of special methods. The outcome
of these studies was to prove that there are separate biological
types among hremolytic streptococci, just as there are among
other apparently closely related groups of microorganisms. More
than 68 per cent. of the strains investigated comprised six easily
distinguishable serological types.
This study was part of a general investigation of the biology
of streptococcus, and, as a result of the facts developed, Bliss and
Dochez 30 undertook a reinvestigation of the much debated ques-
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tion of the unity of type of the S. hremolyticus so constantly
associated with scarlet fever. An effort was made to answer
Jochmann 's main objection to the etiological relationship of S.
hremolyticus to scarlet fever, namely, that the organism is not
present in every instance of the disease, and that it cannot be
satisfactorily differentiated from hremolytic streptococci asso
ciated with the common septic conditions. Bliss 81 found when
cultures are made from the throat early in the course of scarlet
fever that hremolytic streptococci are present in predominating
numbers in 100 per cent. of individuals examined, thus con
firming the earlier work of Baginsky and Sommerfeld. Immune
sera were then prepared by the inoculation of rabbits with
scarlet fever streptococci, and the capacity of these sera to agglu
tinate specifically a large number of freshly isolated scarlet fever
strains was tested. Ten such sera were prepared from different
strains of scarlet fever streptococci and each serum was found
to agglutinate more than 80 per cent. of the strains isolated from
scarlatina! throats. Agglutinating sera prepared from strains
of hremolytic streptococci derived from pathological sources
other than scarlet fever in general, failed to agglutinate spe
cifically the scarlatina! strains. Furthermore, strains of hremo
lytic streptococci obtained from such conditions as tonsillitis,
erysipelas, bronchopneumonia, and other septic diseases, as well
as the various type streptococci, determined by Dochez, Avery
and Lancefield were not agglutinated by the scarlatina! anti
streptococcic sera. The evidence in favor of the specificity of the
agglutination reaction of scarlatina! streptococci was reinforced
by r!)sults obtained from agglutinin absorption experiments.
Scarlatina! streptococcic sera also afforded some protection of
experimental animals against virulent scarlet fever streptococci,
but had no protective power against hremolytic streptococci from
other sources. This work indicates that the majority of hremo
lytic streptococci found in association with scarlatina belong to
a specific biological group and can, by appropriate methods, be
distinguished from hmmolytic streptococci derived from other
pathological conditions. These observations, I believe, confirm
in a satisfactory manner the early studies of Moser and von Pir-
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quet on the same subject. Contemporaneously with Bliss, Tunni
cliff 32 investigated, by means of the opsonic and agglutination
reaction, a series of hremolytic streptococci isolated from patients
during the early stages of scarlet fever. She concludes that the
serum of sheep immunized with hremolytic streptococci from the
throat in the acute stage of scarlet fever contains opsonins and
agglutinins for the hremolytic streptococci that prevail in the
throat and complicating lesions early in this disease, but not for
bremolytic streptococci from other sources, such as erysipelas,
mastoiditis, measles, influenza, diphtheria and the normal throat.
The results of her absorption experiments also indicate that the
hremolytic streptococcus from scarlet fever forms a distinct group,
scarlatina! streptococci removing the opsonins and agglutinins
for these cocci while absorption with a hremolytic streptococcus
from erysipelas has no such effect. These results also suggest
that the hremolytic streptococci from scarlet fever form a distinct
serologic group. Somewhat later Gordon 33 found that eighteen
strains of hremolytic streptococcus isolated from scarlatina were
identical in their agglutinative reactions. None of these strains
absorbed the agglutinins from immune sera prepared from cer
tain other types of hremolytic streptococcus, designated by him
as Types I and IL On the basis of this evidence, Gordon con
cludes that the streptococci from the throat secretions in scarlet
fever constitute a group immunologically distinct from other
varieties of streptococcus pyogenes. Eagles 84 in a recent study
compared the serological reactions of hremolytic streptococci
from scarlet fever, puerperal sepsis, erysipelas and miscellaneous
sources.- He confirms the immunological specificity of the scar
latina! group and the clearness with which it can be separated
from other types of streptococcus. He furthermore compared in
an interesting manner a number of individual strains obtained
at three to four day intervals from the same patient and demon
strated a gradual but progressive loss of specific agglutinability,
a phenomenon which we have observed, and of which I shall
say more later. Williams 86 has also studied the serological reac
tions of the scarlatina! streptococci and finds only 35 per cent.
to belong to a single type, and is of the opinion that a greater
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variability exists than is suggested by the work of the previous
observers. Dick and Dick 36 have shown two strains of scarlet
fever streptococci, one a mannite fermenter, and the other a
non-ma.nnite fermenter, to be serologically distinct, and believe
that the agglutination reaction is of but little importance in
determining the character of the scarlatinal streptococci.
It would seem, therefore, that the old question stressed by
,Tochmann, concerning the specificity of the streptococcus of scar
let fever still remains in dispute. The preponderance of evi
dence, however, strongly favors the belief that these cocci
comprise a separate biological group and that the best method
for determining this specificity of type is by agglutination. In
order that satisfactory results may be obtained from this reac
tion certain rigid conditions must be complied with; spontaneous
auto-agglutination must be prevented, and the streptococci in
question must be studied fresh from their human environment.
This latter requirement is of great significance. Recent studies
by Avery and Heidelberger 87 have shown that the type specificity
of pneumococcus is dependent upon the chemical constitution
of the capsular substance. The production of this substance is
a variable function of the organism; it is greatest in its strictly
parasitic phase and is reduced by all factors which reduce viru
lence and lessen pathogenicity. That a similar loss of a specific
function by scarlatina.I streptococci takes place when they are
removed from their parasitic environment is extremely likely.
Bliss and Stevens and Dochez 88 have emphasized the rapidity
with which specific agglutinating qualities are lost upon con
tinued growth of these streptococci in artificial medium and
Eagles suggests that the same change may take place under the
influence of the immune bodies formed by a scarlatina.I subject
during convalescence. The suppression of specificity of serolog
ical reaction under the influence of immune bodies is, of course, a
well recognized and established phenomenon among the pneumo
cocci. The results obtained, therefore, indicate that if a large
number of strains of scarlatina.I streptococci are studied under
appropriate conditions and within a short period of time from
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their isolation during the acute stage of scarlet fever a high
degree of serological specificity can be demonstrated.
Streptococcus scarlatinre is found not only in the throats and
organs of individuals suffering from anginal types of scarlet feveT
but has also been obtained from atypical forms of the disease,
healthy carriers and contaminated food products. Serologically
specific streptococci have been isolated from the local lesions in
scarlet fever arising from the infection of wounds and burns,
from the throat in scarlet fever without a rash, and from the
lochial discharge in instances of puerperal scarlet fever. Bliss
succeeded in tracing a small outbreak of scarlatina in an isolated
children's institution to a recently admitted healthy carrier of
Streptococcus scarlatinm. Stevens and myself identified by
means of agglutination and absorption reactions as scarlatina!
streptococci organisms isolated both from the contaminated milk
which had given rise to a milk-borne epidemic of scarlet fever,
and from the throats of patients who contracted the disease from
this milk. As a result of these studies the importance of Joch
mann 's objections to Streptococcus scarlatinre as the etiological
agent of scarlet fever was much lessened and students again
began to take an active interest in this organism as the probable
cause of the disease.
From the very beginning of the study of scarlet fever efforts
have been made to produce the disease experimentally in animals
and in man by inoculation with scarlatina! material. Most of
these attempts have had in view the demonstration of an unknown
virus of the filter passing type. Streptococcus scarlatinro, in spite
of the presumptive evidence in its favor and of the fact that some
of the most typical examples of scarlet fever in animals have been
associated with its presence bas been but little tested for its
capacity to produce the disease experimentally. Class 39 in 1899
reported the experimental production of this disease in swine
by an organism designated hy him as Micrococcus scarlatinre.
This was a gram negative coccus isolated from three hundred
cases of scarlet fever and was, in all probability, a streptococcus.
Krumwiede, Nicoll and Pratt 40 in 1914 observed an accidental
infection of a laboratory worker, who sucked into her mouth a
10
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mixture of living streptococci containing Streptococcus scarla
tinru. Three days later this individual developed a sore throat
and subsequently experienced a typical attack of scarlet fever
with all the usual phenomena. Because of the interest aroused
by this observation, efforts were made to infect monkeys with
the same streptococcus, but no instance of the disease was suc
cessfully produced.
In 1921 Dick and Dick 41 made a series of human inoculations
with certain organisms obtained from the throats of individuals
suffering from scarlet fever. Among the organisms utilized for
this purpose was Streptococcus scarlatime. 'l'hough some of the
volunteers experienced sore throats as a result of the treatment,
no true instance of experimental scarlet fever resulted. In 1923
the same workers 42 repeated their efforts to produce scarlet fever
in human volunteers. In the second series of observations a
hremolytic streptococcus obtained from the infected finger of a
nurse suffering from wound scarlet fever was used for purposes
of inoc,ulation. Five volunteers were inoculated by swabbing
the tonsils and pha1·ynx with four-day-old cultures of the strep
tococcus in question. Three of these individuals remained with
out evidence of infection and one suffered from sore throat and
fever without a rash. The fifth volunteer, however, who had
been inoculated with the streptococcus after three weeks' growth
in artificial medium experienced a typical but mild attack of
scarlet fever, beginning forty-four hours after inoculation, and
characterized by sore throat, general malaise, nausea, fever, leu
cocytosis, a typical rash and albuminuria. Desquamation began
on the hands and feet on the tenth day, and was complete by the
end of the fourth week. Five volunteers inoculated with filtrates
of the above-mentioned organism remained well and showed
neither sore throat nor rash. Subsequent inoculation of four of
these volunteers with living unfiltered cultures of the original
streptococcus resulted in the experimental production of another
instance of scarlet fever. These observations were confirmed
later by the same investigators 43 by the experimental production
of another instance of· scarlet fever in an individual proven
susceptible by the nse of a skin test devised by them.
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In 1920 Dochez and Bliss, while studying the biological reac
tions of Streptococcus scarlatinre, observed in a dog infected
subcutaneously with living organisms, the development of an
intense general erythema followed later by desquamation.
Attempts to reproduce this phenomenon in dogs resulted in fail
ure. Stevens and Dochez later tried other animals, including
monkeys, without success. Failure in these instances seemed to
be due to our inability to induce a local infection because of the
low virulence of the organism for the animals employed. Finally
Dochez and Sherman 44 were successful in producing in guinea
pigs and young swine a series of manifestations comprising some
of the principal phenomena of scarlet fever. Successful local
infection was achieved by injecting melted agar subcutaneously
and infiltrating the mass with living culture of Streptococcus
scarlatinre. Since it had become increasingly evident that scar
latina has a certain resemblance to diphtheria, in that there is
a local infection in the throat from which the specific toxic sub
stance is distributed, we hoped that a similar absorption of toxic
material would take place from the local area of infected agar.
This proved to be the case and guinea-pigs and swine treated in
the manner described developed an erythematous rash, fever,
leucocytosis and progressive loss of weight. From eight to twelve
days following infection the swine had general scaly desquama
tion and the guinea-pigs slight general desquamation and com
plete separation of the skin over the pads of the feet. This
phenomenon could not be induced when hremolytic streptococci
from sources other than scarlet fever were utilized. Some of the
guinea-pigs died acutely from the toxic substances absorbed
from the locally inf.ected area, and after death streptococci
could not be demonstrated by culture either in the blood or
serous cavities.
The production of experimental scarlet fever in human beings
and in animals by inoculation with Streptococcus scarlatinre
had by this time made it increasingly likely that this organism is
the causative agent of the disease. The evidence in favor of the
absorption from the area of local infection of a toxic substance
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which might be responsible for the clinical picture, had again
brought into the foreground the analogy with diphtheria.
Investigators of scarlet fever have for many years been
impressed with the similarity of this disease to diphtheria.
Berge, 46 as early as 1895, suggested that scarlatina is due to a
local infection in the throat with streptococcus and that the gen
eral symptoms of the disease are due, as in diphtheria, to the
absorp.tion into the general circulation of soluble toxins formed
by the infecting microorganism at the site of the local disease.
Gabritchewsky and his co-workers, in their studies of scarlatini
form manifestations which followed immunization of human
beings against scarlet fever by means of vaccines of killed cul
tures of streptococcus scarlatinre, attributed these reactions to
the presence of a toxin in the vaccines. They drew attention to
the absence of a vaccine erythema in individuals who gave a
history of having had scarlet fever, and its failure to develop in
patients during the period of convalescence from this disease.
Much evidence in favor of the existence of a soluble circu
lating poison in scarlet fever has also come from the study of
the so-called Schultz-Charlton extinction phenomenon. In 1918
Schultz and Charlton • 0 discovered that if one injects into the
skin of a scarlet-fever patient with a bright red rash 1 cc. of
serum from a normal person, or from a patient convalescent
from scarlet feyer, there appears after a time at the site of the
injection a characteristic change. This change begins after about
six hours and consists in a complete blanching of the rash over
an area of from one-half inch to a few inches in diameter. In
the affected area the swollen follicles, which are a feature of
many rashes, disappear. Looked at from a distance, the margin
of the defect in the rash is generally sharply defined. The color
of the blanched area is that of normal skin and the duration of
the typical phenomenon coincides on the whole with that of the
rash itself. On the other hand, serum taken from scarlet-fever
patients during the acute stage of the illness invariably gave
negative results. Subsequent investigators abundantly corrobo
rated the accuracy of the observation of Schultz and Charlton.
As a result of these later studies it was established that the serum
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of about sixty per cent. of normal ·adults possesses the capacity
to blanch the rash in an active case of scarlet fever; that con
valescent scarlatina! serum gives a positive rash extinction test
in from 80 to 100 per cent. of instances; and that the serum dur
ing the active stages of scarlet fever never manifests blanching
power. The Schultz-Charlton reaction was first used as a diag
nostic test of scarlet fever, and the capacity to extinguish the
rash in scarlet fever was believed to be due to a normal property
of human serum, which is temporarily lost during the acute
stage of scarlet fever and regained during convalescence.
In 1923 Mair 47 published a study of the Schultz-Charlton
reaction in which he confirmed in general the observations of
previous workers but gave the phenomenon a much more satis
factory explanation. He had an opportunity of studying the
blanching power of the serum of a child both before and after
an attack of scarlet fever and showed that the serum before
the attack gave a negative Schultz-Charlton test, but during
convalescence acquired the capacity to extinguish an active rash.
This disproved the previous belief that a positive reaction was
due to some property of normal human serum which is lost dur
ing the acute stages of scarlet fever. He also showed that the
sera of young children who had not had scarlet fever give a
negative reaction in a much greater proportion of instances than
do adult sera and that the reactivity of the sera of new-born
infants corresponds with that of the mothers.
Mair had been interested for some years in the resemblance of
scarlet fever to diphtheria. As a result of his later work, he
came to believe that the rash and other changes in the skin in
scarlet fever are due to a scarlatina! toxin which has entered
into combination with the tissue cells. Among the affected cells
are those contractile elements which have been shown to exist
even in capillary blood-vessels, and to the function of which the
normal tone of the capillaries is due. The toxin interferes with
the function of these cells and a loss of tone of the capillaries
results in the erythema and exudative phenomena with which we
are familiar in the scarlatina! rash. He supposes that the serum
giving a positive Schultz-Charlton reaction contains an antitoxin
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which is able to dislodge and neutralize the toxin fixed in the
cells, and thus restores their normal function over the area
injected. He adds that the true causal organism when discov
ered should be capable of producing a toxin, and that the immu
nization of animals to this poison should give rise to an antito,xin
capable of producing a positive Schultz-Charlton reaction
in man.
·we also had been pondering over the analogy between scarlet
fever and diphtheria and, at the time of the publicatoin of Mair's
observations, had already produced in horses by immunization to
Streptococcus scarlatina; an antitoxic serum of the type postu
lated by him. Struck by the fact that occasionally in guinea
pigs inoculated for the production of experimental scarlet fever
sufficient poison was absorbed from the local lesion to kill the
animals acutely, we determined to make use of the method for
the production of an antitoxic serum in horses. Masses of melted
nutrient agar were injected beneath the skin and then infiltrated
with increasing doses of Streptococcus scarlatinre. The animals
experienced a general reaction, and some of them, curiously
enough, showed loss of hair and extensive general desquamation.
After nine months' immunization the first animal was bled and
his serum tested by Blake, 'frask and Lynch 48 for its corre
spondence with human convalescent scarlatina! serum. When
injected intracutaneously in a patient with a bright rash in the
acute stage of scarlet fever this serum caused a complete extinc
tion of the rash over an area five to ten centimetres in diameter.
The blanching appeared in from six to twelve hours following
injection of the serum and persisted throughout the course of the
disease. As a rule, the characteristic pigmentation and desquam
ation were absent during convalescence over the blanched area.
Antisera prepared from other hremolytic streptococci and from
Streptococcus scarlatinre injected intravenously into animals,
failed to induce blanching of the rash. Furthermore, scarlatini
form rashes in such conditions as erysipelas, measles, and other
exanthematic diseases were not influenced by the intracutaneous
injection of the scarlatinal antitoxin. Injection of a sufficient
quantity of the serum intramuscularly in a patient in the exan-

F1a. !.-Blanching of skin in human scarlet fever due to intracutancous injection of scar
lutinal strep. antitox. (Blake, Trask & Lynch.)

F1G. 2.-Dcsquamation following experirncnta1 scarlet fever in guinea-pigs.
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Jl1a. 3.-Analysis of effect of treatment of scarlet fever with scarlatinal streptococcus
antitoxin. (Blake & Trask.)

Fie. 4.-Cornparative duration of rash in untreated patients and patients treated with
scarlatinal streptococcus antitoxm. (Blake & Trask.)
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thematous stage of scarlet fever causes a complete fading of the
rash over the whole body in from twelve to twenty-four hours.
Blake and Trask 40 have demonstrated that there is present
in the circulating blood and in the urine during the acute stage
of scarlet fever a toxic substance which causes an erythematous
reaction when injected intracutaneously in individuals whose
blood serum gives a negative rash extinction test. This sub
stance appears to be identical with the culture toxin of the Dicks
and circulates in the blood for several days. When patients with
scarlet fever having easily demonstrable amounts of this poison
in the blood are injected with scarlatinal antitoxin, the circu
lating toxin is rapidly neutralized, a single dose of forty cubic
centimetres causing its complete disappearance throughout the
remaining course of the disease. The antitoxin quickly pre
dominates in the blood and the treated patients' serum acquires
the capacity to induce a positive Schultz-Charlton extinction
test, a property that does not develop in untreated patients
until late convalescence. The other toxic manifestations of the
diseases are likewise favorably influenced. An immune horse
serum, therefore, prepared in the manner described, seems to
contain a potent antitoxin and behaves in every way in a man
ner similar to human convalescent scarlet fever serum.
The further studies of Dick and Dick " 0 demonstrating the
presence of a toxic substance in filtrates from blood broth cul
tures of Streptococcus scarlatinre have brought to light a number
of new and important facts which develop still further the
analogy between scarlet fever and diphtheria. The toxic filtrate
was obtained by these authors from a strain of streptococcus with
which they had produced experimental scarlet fever in man.
When individuals who give a negative history for scarlet fever
are injected intracutaneously with small amounts of this toxin,
within about six hours there appears at the site of inoculation a
small circular area of erythema, wh_ich increases in size and
intensity of color for from eighteen to thirty-six hours. Fre
quently the local reaction is accompanied by swelling of the
skin. ·when a series of normal persons who have not had scarlet
fever a.re injected with this substauce, 41.6 per cen,t. of t4cse
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show a positive erythema reaction in the skin, a manifestation
resembling the Schick test for susceptibility to diphtheria. The
remainder who give a negative reaction are considered to be
immune, because of the probable presence of circulating anti
toxin in the blood, just as in the case of diphtheria. In addition,
patients who are recovering from scarlet fever when tested intra
cutaneously with this substance, give but a very faintly positive
or uniformly negative skin reaction. • A similar condition of
affairs is found to exist among those who have had scarlet
fever at some earlier period of life. If individuals who have
been proven susceptible to scarlet fever by means of the Dick
test, are injected subcutaneously with larger amounts of the
toxin, they exhibit certain of the toxic manifestations of the
disease, such as nausea and vomiting, fever and an erythematous
rash. Vi7hen toxic filtrate is mixed in v,,:tro with a small amount
of convalescent scarlet fever serum, its capacity to produce a
positive skin reaction is completely neutralized. Neutralization
of the reaction was also obtained in vivo by the injection into
susceptible human beings of larger quantities of convalescent
serum. More recent studies of the Dicks 51 have shown that
individuals who re.act positively in the skin can be immunized
by repeated doses of the toxin, Ro that within a relatively short
period of time the skin reaction becomes negative, and there
is some evidence to support the belief that such individuals may
he immune to the disease scarlet fever.
Zingher,62 in an extensive study, has confirmed the observa
tions of the Dicks and extended them somewhat. He has shown
that the Dick reaction is positive in the early stages of scarlet
fever in most instances, and that it becomes increasingly negative
as the disease progresses through convalescence. He has, fur
thermore, drawn a very close analogy between the data obtained
from the Schick test in diphtheria and those obtained from the
Dick test in scarlet fever. In general, susceptibility to the latter
reaction is greater in childhood and diminishes in adult life.
There is also an inherited resistance to the toxin in infants whose
mothers exhibit a negative reaction.
These studies, therefore, indicate that there is present in
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sterile filtrates from cultures of Streptococcus scarlatinre a toxic
substance which bears a specific relationship to scarlet fever.
By means of this substance it is possible to detect susceptibility
in persons who have not suffered from scarlet :fever, and further
more to demonstrate the development of immunity in patients
who are recovering from an attack of the disease. This work
brings further strong support to the belief that Streptococcus
scarlatime is the etiological agent of scarlet fever.
In 1921 Di Cristina/ 3 in Italy, obtained from the blood of
patients with scarlet fever an anrerobic Gram-positive diplo
coccus. Other Italian inYestigators subsequently isolated a simi
lar organism from the nasopharynx, bone marrow, spleen and·
desquamating skin of children with scarlet fever. This organ
ism, on further study, was found to show specific serological
reactions with the serum of recovered cases of scarlatina. Inocu
lation of children with living cultures of the organism is said to
have produced an attenuated form of scarlet fever. Further
more, prophylactic inoculation with killed cultures prevented the
development of scarlet fever among a number of children exposed
to the disease. Unfortunately, we are not in a position as yet to
determine with any assurance the significance of this organism
in scarlet fever, since an opportunity to study it bacteriologically
has not been afforded.
Have we now reached the end of man's long struggle to find
the cause of this interesting and at times formidable and dan
gerous disease 1 Personally, I think we have. Belief that scarlet
fever may be caused by a protozoan parasite, or by one of the
mysterious ultramicroscopic viruses, must, I think, be discarded
in view of the fact that the evidence brought forward in sup
port of the causative relationship of such types of microorgan
isms to the disease is entirely unconvincing. On the other hand,
can we say with certainty that scarlet fever is caused by a type
of Streptococcus hmmolyticus 1 Certainly a chain of evidence
in favor of this organism has been patiently and progressively
forged which is as strong as that in many diseases whose etiology
is now accepted without discussion. The constant association
of this organism w
· ith the primary and secondary manifestations
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of the disease, its specific character, its capacity to produce the
experimental disease in man and in animals, the ability of
human convalescent scarlet-fever serum to neutralize the toxic
effects of this streptococcus, the capacity of an antistreptococcus
horse serum antitoxic in nature to counteract the specific toxic
manifestations of the disease in man, and finally the isolation
from Berkefeld filtrates of this streptococcus of a toxic substance
which bears a specific relationship to immunity in scarlet fever,
leaves little room to doubt that Streptococcus scarlatinre is the
principal and probably only etiological agent of scarlet fever.
Let us, therefore, be optimistic and assume that a just reward
has come to those many soldiers in the army of science, too
numerous to be mentioned in so short an exposition, and that
another disease has been added to those about which the essential
specific facts are known. Let us also hope that the methods of
prevention and treatment based on these facts may prove
as successful as the promising character of the preliminary
work suggests.
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